260 related articles for article (PubMed ID: 3594084)
1. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
Sanger GJ
Br J Pharmacol; 1987 May; 91(1):77-87. PubMed ID: 3594084
[TBL] [Abstract][Full Text] [Related]
2. Blockade of 5-HT-mediated enteric slow EPSPs by BRL 24924: gastrokinetic effects.
Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1989 Sep; 257(3 Pt 1):G386-96. PubMed ID: 2782410
[TBL] [Abstract][Full Text] [Related]
3. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
4. Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus.
Kilbinger H; Pfeuffer-Friederich I
Br J Pharmacol; 1985 Jun; 85(2):529-39. PubMed ID: 3161573
[TBL] [Abstract][Full Text] [Related]
5. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
Sanger GJ; Nelson DR
Eur J Pharmacol; 1989 Jan; 159(2):113-24. PubMed ID: 2540014
[TBL] [Abstract][Full Text] [Related]
6. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal motility stimulating drugs and 5-HT receptors on myenteric neurons.
Nemeth PR; Gullikson GW
Eur J Pharmacol; 1989 Aug; 166(3):387-91. PubMed ID: 2806367
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
[TBL] [Abstract][Full Text] [Related]
10. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors.
Taniyama K; Nakayama S; Takeda K; Matsuyama S; Shirakawa J; Sano I; Tanaka C
J Pharmacol Exp Ther; 1991 Sep; 258(3):1098-104. PubMed ID: 1890614
[TBL] [Abstract][Full Text] [Related]
11. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
12. Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.
Burke TA; Sanger GJ
Br J Clin Pharmacol; 1988 Sep; 26(3):261-5. PubMed ID: 3179166
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors.
Kilbinger H; Gebauer A; Haas J; Ladinsky H; Rizzi CA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):229-36. PubMed ID: 7609775
[TBL] [Abstract][Full Text] [Related]
14. Activation of a myenteric 5-hydroxytryptamine-like receptor by metoclopramide.
Sanger GJ
J Pharm Pharmacol; 1987 Jun; 39(6):449-53. PubMed ID: 2886602
[TBL] [Abstract][Full Text] [Related]
15. R 50 595, a selective non-competitive antagonist of cisapride, BRL 24924 and 5-hydroxytryptamine on the guinea-pig ileum.
Van den Brink HW; Schuurkes JA; Van Nueten JM; Van Rossum JM
Eur J Pharmacol; 1990 May; 181(1-2):119-25. PubMed ID: 2387319
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
[TBL] [Abstract][Full Text] [Related]
17. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea pig ileum: antagonism by tropisetron and DAU 6285.
Tonini M; Candura SM; Onori L; Coccini T; Manzo L; Rizzi CA
Life Sci; 1992; 50(21):PL173-8. PubMed ID: 1315899
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
Waikar MV; Hegde SS; Ford AP; Clarke DE
J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
[TBL] [Abstract][Full Text] [Related]
20. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon.
Costa M; Furness JB
Br J Pharmacol; 1979 Feb; 65(2):237-48. PubMed ID: 32947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
